EU urges member states to re-embrace AstraZeneca vaccine

Posted by on April 23, 2021 12:48 pm
Categories: Global Stories

Call comes after European Medicines Agency reaffirms benefits outweigh very small risk of blood clots

Brussels has encouraged EU member states to act on a new European Medicines Agency opinion that the benefits of the Oxford/AstraZeneca Covid vaccine outweigh the risks of blood clots in all adult age groups.

The European commissioner for health, Stella Kyriakides, emphasised the vaccine’s importance as part of the EU’s strategy despite months of controversy following the latest conclusions from the EMA.

Continue reading…

Leave a Reply

Your email address will not be published.